Bortezomib/Dexamethasone/Panobinostat Regimen

Preferred Label : Bortezomib/Dexamethasone/Panobinostat Regimen;

NCIt synonyms : Panobinostat-Bortezomib-Dexamethasone Regimen; Farydak/Velcade/Dexamethasone; Panobinostat-Bortezomib-Dexamethasone; Panobinostat/Bortezomib/Dexamethasone; Panobinostat/Bortezomib/Dexamethasone Regimen;

NCIt related terms : Bortezomib and Dexamethasone (Vd) and Panobinostat;

NCIt definition : A chemotherapy regimen consisting of panobinostat, bortezomib and dexamethasone that is used for the treatment of plasma cell myeloma.;

NCI Metathesaurus CUI : CL523586;

Codes from synonyms : 27175;

Details

Origin ID

C136275;

UMLS CUI

C4526546;

Est indiqué pour
- Recurrent Multiple Myeloma [NCIt concept]
- Refractory Multiple Myeloma [NCIt concept]
Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Bortezomib [NCIt concept]
- Dexamethasone [NCIt concept]
- Panobinostat [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]
regimen_has_accepted_use_for_disease
- Multiple Myeloma [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients